This content is restricted.
Brief
"On March 07, 2025, the Food and Drug Administration (FDA) issued an update regarding FDA Roundup: March 7, 2025. The agency approved Encelto for adults with idiopathic macular telangiectasia type 2, a rare progressive eye disease, and expanded neffy's indication to include children four years old and older who weigh at least 15 kg."
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested